FDA wants to limit compounded versions of weight loss drugs

The proposal could affect telehealth services that rely on outside facilities to produce the knockoff drugs in bulk.

Food and Drug Administration (FDA): What It Is and Does

The Food and Drug Administration is a government agency that regulates certain food, drugs, cosmetics, and medical products.
STAT

Katherine Szarama named acting director of FDA’s vaccines and biologics center

Katherine Szarama, who joined the FDA last year to serve as Vinay Prasad’s deputy, will now fill his shoes at CBER.

FDA moves to exclude weight loss drugs from compounding chemicals list

The FDA has moved to exclude semaglutide, tirzepatide and liraglutide -- which are in several popular weight loss drugs -- ...

FDA advises users of Trividia glucometer to switch to alternatives

The potential for error code confusion to cause delayed or improper treatment led the FDA to recommend users transition to ...
STAT

FDA wants to exclude weight loss drugs from a compounding list

FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's no shortage of ...
FOX6 News Milwaukee

Infant formula safety study results released by FDA

The FDA released findings from its largest test on infant formula, focused on chemical contaminants and overall safety.
Regulatory Affairs Professionals Society

FDA warns three firms for GMP violations, cites Incyte for misleading claims

The US Food and Drug Administration (FDA) recently issued three warning letters to facilities in China, the US, and India for ...

US FDA approves Axsome's drug for Alzheimer's-related agitation

By Kamal Choudhury and Mariam Sunny April 30 (Reuters) - The U.S. Food and Drug Administration has approved Axsome ...
Medical Marketing & Media

Fresh off ruling in J&J case, Bayer’s Nubeqa ad runs afoul of FDA

Bayer received an FDA Untitled Letter this week for its prostate cancer drug Nubeqa, shortly after it launched a lawsuit ...
MPR

FDA Pauses US Enrollment for Phase 3 Evenamide Schizophrenia Study

The Food and Drug Administration (FDA) has placed a hold on the enrollment of new patients in the phase 3 ENIGMA-TRS 2 study evaluating evenamide in treatment-resistant schizophrenia.